Home
Our Technology
Trials
About Us
News
Contact Us
Menu
Home
Our Technology
Trials
About Us
News & Events
Contact Us

News, Events & Publications

Read our press releases, view clinical trial publications and find out where you can meet us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Preclinical evaluation of sentinel node localization in the stomach via mannose-labelled magnetic nanoparticles and indocyanine green

Preclinical evaluation of sentinel node localization in the stomach via mannose-labelled magnetic nanoparticles and indocyanine green

August 2023
Publications
Read more
Fibroblast Activation Protein-Specific MRI Provides Improved Tumour Mapping in an Orthotopic Model of Prostate Cancer Compared to Prostate Specific Membrane Antigen

Fibroblast Activation Protein-Specific MRI Provides Improved Tumour Mapping in an Orthotopic Model of Prostate Cancer Compared to Prostate Specific Membrane Antigen

1 May 2022
Publications
Read more
Nanoparticles Targeted to Fibroblast Activation Protein Outperform PSMA for MRI Delineation of Primary Prostate Tumors

Nanoparticles Targeted to Fibroblast Activation Protein Outperform PSMA for MRI Delineation of Primary Prostate Tumors

25 February 2023
Publications
Read more
Preclinical evaluation of a mannose-labeled magnetic tracer for enhanced sentinel lymph node retention in the head and neck

Preclinical evaluation of a mannose-labeled magnetic tracer for enhanced sentinel lymph node retention in the head and neck

June 2022
Publications
Read more
Preclinical feasibility of robot-assisted sentinel lymph node biopsy using multi-modality magnetic and fluorescence guidance in the head and neck

Preclinical feasibility of robot-assisted sentinel lymph node biopsy using multi-modality magnetic and fluorescence guidance in the head and neck

8 September 2022
Publications
Read more
ASCO Gastrointestinal Cancer Symposium 18-20 January 2024, San Francisco

ASCO Gastrointestinal Cancer Symposium 18-20 January 2024, San Francisco

18-20 January 2024
Events
Read more
AGTIG Annual Scientific Meeting 13-16 November 2023

AGTIG Annual Scientific Meeting 13-16 November 2023

13-16 November 2023
Events
Read more
Ferronova and Purdue Research Foundation (PRF) sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy

Ferronova and Purdue Research Foundation (PRF) sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy

August 23, 2023
News
Read more
Feasibility of Magnetic (FerroTrace®) and Indocyanine Green (ICG) Sentinel Lymph Node Mapping in Colorectal Cancer (MAGICSENT Trial)

Feasibility of Magnetic (FerroTrace®) and Indocyanine Green (ICG) Sentinel Lymph Node Mapping in Colorectal Cancer (MAGICSENT Trial)

Apr 27, 2023
Publications
Read more
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

Jan 22, 2023
News
Read more
Fast-tracked: First in-human trial for aggressive brain tumours

Fast-tracked: First in-human trial for aggressive brain tumours

May 12, 2022
News
Read more
Ferronova secures $826,000 BioMedTech Horizons grant funding

Ferronova secures $826,000 BioMedTech Horizons grant funding

Jul 20, 2020
News
Read more
Ferronova secures $3.5m Series A funding led by Uniseed

Ferronova secures $3.5m Series A funding led by Uniseed

May 26, 2020
News
Read more
Ferronova cancer tracers ready for human trials

Ferronova cancer tracers ready for human trials

Oct 30, 2019
News
Read more
UniSA cancer detection technology spin-out. Ferronova brings in Signostics co-founder Stewart Bartlett as chief executive.

UniSA cancer detection technology spin-out. Ferronova brings in Signostics co-founder Stewart Bartlett as chief executive.

Nov 13, 2017
News
Read more
Ferronova’s magnet cancer detection device draws investors

Ferronova’s magnet cancer detection device draws investors

Jun 20, 2016
News
Read more
UniSA’s improved cancer detection technology a magnet for commercialisation

UniSA’s improved cancer detection technology a magnet for commercialisation

Jun 20, 2016
News
Read more
Home
Our Technology
Trials
About Us
News
Contact Us

We're backed by:

Copyright © 2023 Ferronova | Ferronova, MM3-02, MM Building, UniSA, Mawsons Lakes Blvd, Mawson Lakes SA 5095, Australia. Caution: Ferronova products are undergoing clinical trials and are not approved for commercial use. V4.0.

Design + Development Composite